<DOC>
	<DOCNO>NCT03001297</DOCNO>
	<brief_summary>A Phase 1 , single dose study 4 cohort ascend dos optional Japanese cohort design evaluate safety , pharmacokinetics , pharmacodynamics MEDI5884 healthy volunteer .</brief_summary>
	<brief_title>Phase 1 , Single Dose Study Evaluate Safety , Pharmacokinetics , Pharmacodynamics MEDI5884</brief_title>
	<detailed_description>This first time human , phase 1 , randomize , blind , placebo-controlled study evaluate safety , pharmacokinetics pharmacodynamics single ascend subcutaneous dos MEDI5884 healthy volunteer ( age 18-55 ) . The study consist 4 cohort increase dos ( 8 subject ) optional Japanese American cohort ( 24 subject ) total 56 healthy subject . The decision whether dose escalate base upon data review Dose Escalation Committee . Subjects randomize 3:1 MEDI5884 placebo . Following screening , study consist 3 day inpatient stay follow visit . The number follow visit depend cohort assign .</detailed_description>
	<criteria>Healthy volunteer age 1855 year Must provide write informed consent Ability willingness adhere protocol BMI 1830kg/m2 Females childbearing potential Males must practice 2 effective contraceptive measure sexually active Japanese descent Japanese cohort Any concurrent condition opinion investigator would interfere evaluation investigational product History presence gastrointestinal , renal , hepatic disease condition know interfere absorption , distribution , metabolism , excretion drug Abnormal lab value , physical exam , vital sign Any clinically important illness , medical/surgical procedure , trauma within 4 week prior dose Positive Hepatitis B , Hepatitis C HIV test Receipt investigational therapy 6 month screen Current previous use systemic corticosteroid 60 day prior dose lipid lower medication 28 day prior dose Abnormal ECG Recent plasma blood donation Positive drug alcohol screen . Current smoker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>atherosclerosis ; acute coronary syndrome ; MEDI5884</keyword>
</DOC>